Status:
RECRUITING
Prognostic Value of Biomarkers in Polyneuropathy.
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Polyneuropathies
Eligibility:
All Genders
18+ years
Brief Summary
Biomarkers for prognosis of patients with polyneuropathy.
Detailed Description
AIM: To investigate biomarkers' use as a prognostic tool in polyneuropathy patients. STUDY DESIGN: Prospective cohort study of patients with polyneuropathy. METHODS: 200 patients with polyneuropathy ...
Eligibility Criteria
Inclusion
- Minimum 18 years old.
- Diagnosed with polyneuropathy, confirmed by nerve conduction study.
- Can read and understand Danish.
Exclusion
- Inability to perform physical tests due to comorbidity not associated to the patient's polyneuropathy.
Key Trial Info
Start Date :
October 27 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06044662
Start Date
October 27 2023
End Date
October 1 2026
Last Update
April 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Copenhagen Neuromuscular Center, Department of Neurology, Rigshospitalet
Copenhagen, Denmark, 2100